John Scrivano, PA-C

John Scrivano practices at Graybill Physical Therapy in Escondido, California.

John Scrivano's NPI, 1235224395, was assigned on October 4, 2006. John Scrivano holds California license PA14455.

John Scrivano's primary practice is Graybill Physical Therapy, at 225 E Second Avenue Suite 320, Escondido, CA 92025. The practice phone is (760) 291-6700.

John Scrivano's primary practice is Graybill Physical Therapy in Escondido, California. The medical group on file is Graybill Medical Group. Dmand AI also links John Scrivano to 1 more group practice or clinic, named with a free account. John Scrivano's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where John Scrivano practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is John Scrivano's primary specialty in the NPI Registry, under taxonomy code 363A00000X. John Scrivano is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). John Scrivano is licensed in California.

Dmand AI lists acute gastroduodenitis, acute sinusitis, ankle or foot injury, arthritis, benign or precancerous skin growths, bladder disease, chronic obstructive pulmonary disease (COPD) and contact dermatitis among the conditions John Scrivano treats.

CMS data shows 206 Medicare services from John Scrivano across 3 procedure codes in 2024, all of them office visits, for 118 Medicare patients. Medicare paid $13,215 for them. Every service was in an office.

CMS counts 118 Medicare patients who saw John Scrivano in 2024. The largest group is 65 to 74, with 69 patients. 71% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts John Scrivano's median patient age at 64, with 45% women.

In 2024, John Scrivano wrote 1,720 Medicare Part D claims for 226 patients. 77% of them were for generic drugs. CMS names the drug for 1,231 of them, across 41 drugs with 11 or more claims each, at $244,883 in total drug cost.

John Scrivano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 155 general payments to John Scrivano from 17 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $673.

John Scrivano is a member of AAPA.